Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-10

Clinical Trial Update: Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy of sulfadoxine-pyrimethamine for treating malaria in Gabonese children has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Albert Schweitzer Hospital, Netherlands | Conditions: Malaria | Phase 4 | Status: TERMINATED